CDKN2A and meningioma: These seven meningiomas harboring CDKN2A homozygous deletion demonstrated complete absence of p16 expression by immunohistochemistry, with intact staining in non-neoplastic endothelial and inflammatory cells (Fig. 1, Supplementary Fig. 1 [Online Resource 2]).